Kezar Life Sciences Files 8-K on Officer/Director Changes
Ticker: KZR · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1645666
| Field | Detail |
|---|---|
| Company | Kezar Life Sciences, INC. (KZR) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: KZR
TL;DR
Kezar Life Sciences (KZR) filed an 8-K detailing leadership changes and compensation arrangements as of March 27th.
AI Summary
Kezar Life Sciences, Inc. filed an 8-K on April 1, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The report covers events as of March 27, 2025.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance events and does not indicate immediate financial distress or significant operational changes.
Key Players & Entities
- Kezar Life Sciences, Inc. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- April 1, 2025 (date) — Date of report
FAQ
What specific officer or director positions were affected by the events reported on March 27, 2025?
The filing indicates changes related to the departure of directors or certain officers, election of directors, and appointment of certain officers, but the specific names and roles are not detailed in the provided excerpt.
Are there any new compensatory arrangements for officers or directors disclosed in this filing?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specifics of these arrangements are not provided in the excerpt.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated March 27, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed as of April 1, 2025.
What is the primary business of Kezar Life Sciences, Inc. according to the filing?
Kezar Life Sciences, Inc. is categorized under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Kezar Life Sciences, Inc. (KZR).